Medical Value Travel in AR
Medical Value Travel in AR section, includes general infrmation about Medical Value Travel Procedure, Medical Value Travel AR Local News, Medical Value Travel AR Surgeon Locator and other Medical Value Travel related material.
Medical Value Travel Procedure
Currently medical value tourists or medical value travelers from developed industrialized countries are traveling in large numbers abroad where the quality of healthcare is equal to or even better than the standards in their own country and yet the cost is significantly lower. Another factor behind Medical Value Travel is the promptness of treatment. These healthcare destination countries also offer numerous options for escapes to vacation touring trips, sight-seeing, shopping, exploring journeys and lounging on sun drenched exotic beaches for Medical Value Travelers.
A number of reasons have lead to the recent increase in the popularity of Medical Tourism or Medical Value Travel. Some of the reasons include overly exorbitant costs of basic health care and medical insurance cover, high cost of modern medical facilities in advanced countries, ease and affordability of international travel, favorable currency exchange rates in the global economy, rapidly improving technology and high standards of medical care in the developing countries, best medical health care education at the medical schools, proven safety of healthcare in select foreign nations, international accreditation of foreign hospitals and access to U.S., U.K. and Australian board certified surgeons operating in select foreign countries. All of the former contributed their share to this rapid development of Medical Tourism or Medical Value Travel.
In general, most Medical Value Tourists are either uninsured, underinsured or those seeking elective surgeries. Others resort to Medical Value Travel due to the long wait-lists or unavailability of certain procedures in their country.
Cosmetic Surgery procedures which are also known as 'elective' surgical procedures, whether carried out at home or abroad, raise concerns and anxieties for the patient. It is normal to have some doubts about the surgeon or the clinic where the procedure is going to be carried out. Legitimate concerns can also include safety, the qualifications of the surgeon performing the procedure, the after-care service given, the standard of the hospital being chosen, the duration of the flight time in consideration to the procedure being carried out and also the country where you are traveling to - in terms of whether it is somewhere where you will feel comfortable. The language barrier can also be a concern. These are all legitimate concerns which, bring up questions needing to be answered. The more information you can get in advance, the more confident you will be when you travel for surgery.
With an ever increasing demand for these types of procedures, these days a patient can look towards specific companies, which deal solely in putting together packages specifically aimed for cosmetic surgery abroad. These packages not only involve the application of plastic surgery procedures, or patients traveling from their home country to receive the work done, but can also include flights and after surgery accommodation.
For many Medical Value Travel procedures, you begin with convenient initial consultations online from your home. Arriving abroad at the treatment location, you receive private hospital support with nurses visiting your hotel room, then luxury spa treatments to soothe the nerves and comforting recovery kits to ease the pain.
Many consumers locate Medical Value Travel vacation destinations through the Internet. The websites of these destinations have contact forms so that the patient can communicate with the practice by email. Patients often scan a photo of the area that they are interested in improving and send it to the doctor for a recommendation.
Other Medical Value Travel Procedures
All Other Procedures
Medical Value Travel AR (current)
AR Medical tourism
AR Plastic Surgery
AR Plastic Surgeon
AR Cosmetic Surgery
More AR info...
Argentina Language The official language is Spanish. The regional dialect, Rioplatense Spanish, is subtly different from both the language of Spain and that of Central America; most notably, the pronoun "tu" is replaced by "vos" (with seperate verb conjugations, sometimes significantly different for irregular verbs); "y" and "ll" are pronounced ranging from an English "sh" (in Buenos Aires and Patagonia) through a soft "zh" sound, to a sound like English "j" in Cuyo. The interjection "che" is extremely common, and means approximately the same as English "hey!".
The Argentine accent evinces heavy Italian influence from the large influx of Italian immigrants. Hand gestures derived from Italian are extremely common, and many slang expressions are borrowed from Italian. Most locals can readily understand most Spanish dialects, and Portugese or Italian if spoken slowly. English is usually understood on at least a basic level in tourist-oriented places. German and French can be understood and to some extent spoken by small fractions of the population. A few places in Patagonia near Rawson have native Welsh speakers.
Argentina Electricity Argentine electricity is officially 220V 50Hz, with slanted plugs similar to those used in Australia. Adapters and transformers for European and North American equipment are readily available.
The best way to use imported electrical equipment in Argentina is to purchase an adapter once there. These are available in the Florida shopping area in Buenos Aires for around US$2, or less in hardware stores outside the city center. Buildings use a mix of European and Australian plug fittings. However, the live and neutral pins in the Australian fittings are reversed so as to prevent cheap imports into Australia. Therefore an Australian adapter may be incompatible.
Many sockets have no earth pin. Laptop adapters should have little problem with this for short term use.
Argentina's outlets are their own standard, the IRAM-2073, which are physically identical to the Australian AS-3112 standard (two blades in a V-shape, with or without a third blade for ground).
Plastic Surgery News...
Context Individuals with diabetes are at increased risk for cardiovascular disease (CVD), but more aggressive targets for risk factor control have not been tested.
Objective To compare progression of subclinical atherosclerosis in adults with type 2 diabetes treated to reach aggressive targets of low-density lipoprotein cholesterol (LDL-C) of 70 mg/dL or lower and systolic blood pressure (SBP) of 115 mm Hg or lower vs standard targets of LDL-C of 100 mg/dL or lower and SBP of 130 mm Hg or lower.
Design, Setting, and Participants A randomized, open-label, blinded-to-end point, 3-year trial from April 2003-July 2007 at 4 clinical centers in Oklahoma, Arizona, and South Dakota. Participants were 499 American Indian men and women aged 40 years or older with type 2 diabetes and no prior CVD events.
Interventions Participants were randomized to aggressive (n=252) vs standard (n=247) treatment groups with stepped treatment algorithms defined for both.
Main Outcome Measures Primary end point was progression of atherosclerosis measured by common carotid artery intimal medial thickness (IMT). Secondary end points were other carotid and cardiac ultrasonographic measures and clinical events.
Results Mean target LDL-C and SBP levels for both groups were reached and maintained. Mean (95% confidence interval) levels for LDL-C in the last 12 months were 72 (69-75) and 104 (101-106) mg/dL and SBP levels were 117 (115-118) and 129 (128-130) mm Hg in the aggressive vs standard groups, respectively. Compared with baseline, IMT regressed in the aggressive group and progressed in the standard group (–0.012 mm vs 0.038 mm; P < .001); carotid arterial cross-sectional area also regressed (–0.02 mm2 vs 1.05 mm2; P < .001); and there was greater decrease in left ventricular mass index (–2.4 g/m2.7 vs –1.2 g/m2.7; P = .03) in the aggressive group. Rates of adverse events (38.5% and 26.7%; P = .005) and serious adverse events (n = 4 vs 1; P = .18) related to blood pressure medications were higher in the aggressive group. Clinical CVD events (1.6/100 and 1.5/100 person-years; P = .87) did not differ significantly between groups.
Conclusions Reducing LDL-C and SBP to lower targets resulted in regression of carotid IMT and greater decrease in left ventricular mass in individuals with type 2 diabetes. Clinical events were lower than expected and did not differ significantly between groups. Further follow-up is needed to determine whether these improvements will result in lower long-term CVD event rates and costs and favorable risk-benefit outcomes.
Trial Registration clinicaltrials.gov Identifier: NCT00047424
- According to PharmaTimes, the FDA has accepted eltrombopag (Promacta®) for priority review. This agent is an oral platelet growth factor therapy being developed to treat chronic idiopathic thrombocytopenic purpura (ITP).